Andressa Sanches
About Andressa Sanches
Andressa Sanches is an MSL Manager at Bristol Myers Squibb with extensive experience in clinical trials and medical affairs.
Current Position as MSL Manager
Andressa Sanches currently holds the position of MSL Manager at Bristol Myers Squibb. She began her tenure at the company on January 1, 2020. In this role, she oversees medical science liaison activities and ensures the effective communication of scientific data to key stakeholders. Her responsibilities may also include the strategic planning and execution of medical affairs programs to support the company's therapeutic areas.
Previous Roles at Celgene
Prior to her current role, Andressa Sanches worked at Celgene, holding two key positions. From 2019 to 2020, she served as Medical Affairs Manager, and from 2016 to 2019, she was the Medical Science Liaison Manager in Brasil. In these roles, she was responsible for managing medical affairs and ensuring the successful implementation of clinical and scientific communications strategies.
Experience at Amgen and Pfizer
From 2013 to 2016, Andressa Sanches served as Regional Medical Liaison at Amgen, bringing valuable experience in medical liaison activities to the company. Her prior experience includes seven years at Pfizer, where she held several roles: Clinical Operation Lead in 2012 for 11 months, Sr. Clinical Research Analyst from 2005 to 2012, and Clinical Research Associate (CRA) from 2005 to 2012. Her roles at Pfizer emphasized her expertise in clinical research and operations.
Academic Background and Education
Andressa Sanches completed her education at the Pontifícia Universidade Católica de Campinas, where she earned a Pharmacist degree. She studied there from 2000 to 2004. Her academic background in pharmacy laid a solid foundation for her extensive career in the pharmaceutical and medical science sectors.
Clinical Research and Therapeutic Areas Expertise
Andressa Sanches has extensive experience managing clinical trials across multiple therapeutic areas, including Oncology, Diabetes, Pain, Inflammation, Osteoporosis, and Rheumatology. Over a span of nine years, she has been involved in various phases of clinical trials, including phases II, III, and IV. Her comprehensive expertise in these areas underscores her capability in overseeing complex clinical research projects.